Neurology Unit, Department of Neurological Sciences, Christian Medical College, Vellore, Tamil Nadu, India.
Neurol India. 2010 May-Jun;58(3):441-2. doi: 10.4103/0028-3886.65529.
For promptly referral of a patient with acute ischemic stroke (AIS) for possible thrombolysis, general practitioners (GPs) need to equipped with the advanced knowledge of AIS treatment. We assessed the knowledge regarding treatment of AIS among GPs practicing in and around a quaternary care teaching hospital in south India. A total of 109 GPs who attend to medical emergencies were interviewed using a standard questionnaire. Of the 109 GPs interviewed, 54% felt that tissue plasminogen activator (tPA) can be used in the treating AIS, but only 24% had chosen tPA as the best treatment option and 22% opted for other agents like citicholine or edavarone. Only 17% were aware that tPA should be given within 3 h. and 35% felt that intra-arterial thrombolysis as a treatment option.. Only 30% felt the need for good sugar control and 37% wanted aggressive lowering of blood pressure. Majority of GPs are not clear about beneficial effects of thrombolysis and are not updated regarding BP and sugar control in the setting of AIS.
为了及时将急性缺血性脑卒中(AIS)患者转介进行可能的溶栓治疗,全科医生需要具备 AIS 治疗的先进知识。我们评估了在印度南部一家四级保健教学医院及其周边地区执业的全科医生对 AIS 治疗的了解程度。我们使用标准问卷对 109 名处理医疗紧急情况的全科医生进行了访谈。在接受采访的 109 名全科医生中,54%的人认为组织型纤溶酶原激活剂(tPA)可用于治疗 AIS,但只有 24%的人选择 tPA 作为最佳治疗选择,22%的人选择其他药物,如胞磷胆碱或依达拉奉。只有 17%的人知道 tPA 应在 3 小时内给予。35%的人认为动脉内溶栓是一种治疗选择。只有 30%的人认为需要良好的血糖控制,37%的人希望积极降低血压。大多数全科医生不清楚溶栓的有益效果,并且在 AIS 情况下关于血压和血糖控制的信息没有得到更新。